Glenmark Chief On IGI’s Landmark Trispecific Deal: Strong Data Excited AbbVie
Glenmark’s managing director talks about IGI’s billion dollar-plus deal with AbbVie, ISB-2001’s striking data, the BEAT platform, other "exciting" pipeline assets and the "blood, sweat and tears" to get to this stage.